Yanle Zhi

6PUBLICATIONS
11CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsBiologically active moleculesHaematological tumoursCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 16, 2025
Multifunctional Polymer-Modified P-CaO2@Au@OVA@Cu@DHPs Nanoparticles Enhance SARS-CoV-2 mRNA Vaccine-Induced Immunity via the cGAS-STING Signaling Pathway.

Yanle Zhi, Shengchao Wang, Haibo Zhang

|Sep 29, 2025
Diacetylenic Spiroacetal Enol Ethers from Chrysanthemum indicum Alleviates Inflammation in LPS-Induced RAW 264.7 Cells via Regulation of Nrf2 and MAPK Signaling Pathways.

Gui-Min Xue, Hao Feng, Xin-Xin Guo

|Jun 19, 2025
Design, Synthesis, and Biological Evaluation of Potent FLT3 Inhibitor for Acute Myeloid Leukemia (AML) Treatment.

Kun Du, Yanan He, Jinyang Fu

|Jul 18, 2023
Structurally Diverse Phenolic Amides from the Fruits of Lycium barbarum with Potent α-Glucosidase, Dipeptidyl Peptidase-4 Inhibitory, and PPAR-γ Agonistic Activities.

Hui Chen, Wen-Jing Zhang, Jiang-Bo Kong

|Dec 03, 2019
Discovery of Benzo[cd]indol-2(1H)-ones and Pyrrolo[4,3,2-de]quinolin-2(1H)-ones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain with Potential High Efficiency against Acute Gouty Arthritis.

Fei Jiang, Qinghua Hu, Zhimin Zhang

|Jan 23, 2018
Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia.

Yue Wang, Yanle Zhi, Qiaomei Jin

Pageof 1

Frequent Collaborators

2 joint publications

Zhiqiang Zhang

1 joint publications

Hui Chen

1 joint publications

Zhen-Zhu Zhao

1 joint publications

Wei-Sheng Feng